CONSULTING AGREEMENTConsulting Agreement • November 2nd, 2023 • Prothena Corp Public LTD Co • Pharmaceutical preparations • California
This Consulting Agreement (this “Agreement”) is effective as of October 1, 2023 (the “Effective Date”) and is made by and between Dennis J. Selkoe, M.D., an individual (“Consultant”), and Prothena Biosciences Inc, a Delaware corporation with offices at 331 Oyster Point Boulevard, South San Francisco, CA 94080, U.S.A. (“Prothena”). Consultant and Prothena may each be referred to individually herein as a “Party” and collectively as the “Parties”.
GLOBAL LICENSE AGREEMENT by and among PROTHENA BIOSCIENCES LIMITED and CELGENE SWITZERLAND LLC Dated as of July 5, 2023Global License Agreement • November 2nd, 2023 • Prothena Corp Public LTD Co • Pharmaceutical preparations • New York
This GLOBAL LICENSE AGREEMENT (this “Agreement”) is entered into and made effective as of July 5, 2023 (the “Effective Date”) by and between Prothena Biosciences Limited, an Irish limited company (“Prothena”) and Celgene Switzerland LLC, a Delaware limited liability company (“Celgene”). Celgene and Prothena are each referred to herein by name or as a “Party” or, collectively, as the “Parties”.
